Triple G Agonists — A Home Run for Obesity?
Aesthetics Advisor
SEPTEMBER 7, 2023
The New England Journal of Medicine - The buzz was palpable at the 2023 American Diabetes Association Scientific Sessions as multiple new nutrient-stimulated, hormone-based therapies for obesity and type 2 diabetes took center stage. JAMA 2012 ;307: 56 - 65. Only then will obesity management truly hit a home run. References (10) 1.
Let's personalize your content